Ascendis Health Limited

Johannesburg Stock Exchange ASC.JO

Ascendis Health Limited Total Non-Current Liabilities for the year ending June 30, 2024: USD 1.96 M

Ascendis Health Limited Total Non-Current Liabilities is USD 1.96 M for the year ending June 30, 2024, a 35.50% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • Ascendis Health Limited Total Non-Current Liabilities for the year ending June 30, 2023 was USD 1.45 M, a -87.30% change year over year.
  • Ascendis Health Limited Total Non-Current Liabilities for the year ending June 30, 2022 was USD 11.42 M, a -34.46% change year over year.
  • Ascendis Health Limited Total Non-Current Liabilities for the year ending June 30, 2021 was USD 17.42 M, a -96.22% change year over year.
  • Ascendis Health Limited Total Non-Current Liabilities for the year ending June 30, 2020 was USD 460.67 M, a 972.93% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
Johannesburg Stock Exchange: ASC.JO

Ascendis Health Limited

CEO Mr. A. Carl Neethling
IPO Date Nov. 22, 2013
Location South Africa
Headquarters 31 Georgian Crescent East
Employees 3,200
Sector Health Care
Industries
Description

Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Hungary, Romania, and internationally. The company operates through Consumer Health, Pharma, and Medical segments. It offers body and skin products; and natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Nimue, Scitec, Solal, and Vitaforce brand names. The company also provides medical devices, and diagnostic laboratory equipment and consumables for operating theatres, ICUs, trauma units, maternity and general wards, radiology, pathology labs, research and science institutes, etc.; generic pharmaceutical products, antineoplastic agents, antivirals, aromatase inhibitors, anti-infectives; and products for the nervous system, cardiovascular system, dermatological products, and antimalarials, as well as other therapeutic products under the Pharmachem, Reuterina, Sinucon, Clonam, Phlexy, Surgical Innovations, RCA, and The Scientific Group brands. In addition, it exports its products. The company serves pharmacies, retailers, beauticians, and doctors. Ascendis Health Limited was incorporated in 2008 and is based in Johannesburg, South Africa.

Similar companies

AEG.JO

Aveng Limited

USD 0.67

0.47%

SOL.JO

Sasol Limited

USD 5.03

-1.74%

StockViz Staff

January 16, 2025

Any question? Send us an email